West appoints VP, Corporate Development, Strategy and Investor Relations West appoints VP, Corporate Development, Strategy and Investor Relations Quintin Lai joins the US firm from Sigma Aldrich Chalcroft announces new structure following significant growth Chalcroft announces new structure following significant growth Gives new roles to management and makes some promotions Frank Mathias to become CEO of Rentschler Biotechnologie Frank Mathias to become CEO of Rentschler Biotechnologie Nikolaus Rentschler joins supervisory board to concentrate on further expansion of the Rentschler Group Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France Yves Buelens, who has been plant manager since 2014, gains a promotion Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer He beings extensive experience to the newly created role HUYA Bioscience International expands senior management team HUYA Bioscience International expands senior management team Recruits Dmitri Kharkevitch as Vice President for Clinical Development Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer Brings two decades of experience in quality, manufacturing, product safety and regulatory affairs to the firm Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing Will lead business activity concerning SMARTag bioconjugation technology Lonza announces change to Executive Committee Lonza announces change to Executive Committee Sven Abend, Chief Strategy Officer and member of the Executive Committee, takes responsibility for Specialty Ingredients from Beat In-Albon Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development New role strengthens Immune's ability to advance portfolio through strategic partnering Joseph P. Hagan becomes Chief Operating Officer at Regulus Joseph P. Hagan becomes Chief Operating Officer at Regulus He brings nearly 15 years of experience to the La Jolla, CA, US-based firm Belgian biotech Promethera makes two senior appointments Belgian biotech Promethera makes two senior appointments Dr Jürgen Beck is hired as VP Clinical and Medical Affairs, with Patrick Stragier as VP Operations Schott researcher receives Turner Award Schott researcher receives Turner Award Professor Volker Rupertus is honoured for his involvement in the International Commission on Glass Abzena hires Dr Campbell Bunce to new role of SVP Scientific Operations Abzena hires Dr Campbell Bunce to new role of SVP Scientific Operations Adds further immunology expertise to the Executive Management Team Auspherix appoints Dr Neil Miller as Chief Scientific Officer Auspherix appoints Dr Neil Miller as Chief Scientific Officer He spent two decades in the pharmaceutical industry at GlaxoSmithKline Catherine Turkel joins OticPharma as Chief Development Officer Catherine Turkel joins OticPharma as Chief Development Officer Will lead the firm's preclinical, clinical, regulatory and CMC functions in the US